Private industry has been urged to join a public sector commitment to fund advanced manufacturing research and development in bioprocessing.
26 November, 2009
MedImmune has announced the winners of its European research abstract competition, which highlights the work of tomorrow's budding scientific leaders in cancer research.
25 November, 2009
Astex Therapeutics announced recently that it has been granted orphan drug designation by the FDA for AT9283, its combinatorial oncogenic kinase inhibitor, for the treatment of patients with acute myeloid leukaemia.
24 November, 2009
Researchers have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains.
23 November, 2009
Heptares Therapeutics Ltd has announced the grant of a core patent in the UK on its technology for generating stabilized GPCRs (StaRs) and a series of UK patents on specific StaRs and their use in drug screening (GB2456235, GB2456237, GB2456904 and GB2456236).
20 November, 2009
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010.
19 November, 2009
The Food and Drug Administration has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia, a serious complication that can occur after a bout with shingles.
18 November, 2009
One difficulty with fighting cancer cells is that they are similar in many respects to the body’s stem cells. By focusing on the differences between the two cell types, researchers have found a new way of tackling colon cancer.
17 November, 2009
'Visions of Discovery', a new exhibition featuring stunning images arising from biological and medical research, has opened at the University of Dundee.
16 November, 2009
Astex Therapeutics Limited announced recently that it has entered into a new collaboration agreement with GlaxoSmithKline (GSK) to discover, develop and commercialize novel compounds directed against multiple therapeutic targets of interest to GSK.
13 November, 2009
The GSM Association today announced that it has signed a Memorandum of Understanding with the University of Manchester to establish an m-Health Innovation Centre in Manchester, which will act as a UK focus for m-Health activity.
11 November, 2009
Researchers at the Swedish medical university Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories.
10 November, 2009
Germany's Paul-Ehrlich-Institute approves clinical trial in rheumatoid arthritis patients.
09 November, 2009
Astex Therapeutics Limited recently announced the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute to collaborate on the study of its novel small-molecule HSP90 inhibitor, AT13387, for the treatment of cancer.
06 November, 2009
This will be the first evaluation of CureVac's RNActive® vaccine technology in humans.
05 November, 2009
TikoMed AB announced recently that IBsolvMIR® has been granted orphan drug designation for the prevention of graft rejection during pancreatic islet transplantation by the Committee for Orphan Medicinal Products of the EMEA.
04 November, 2009
The European Medicines Agency has been formally notified by AstraZeneca of its decision to withdraw its application for a centralized marketing authorization for the medicine Zactima (vandetinib) in 100 mg film-coated tablets.
02 November, 2009